Greenwich Lifesciences Inc
NASDAQ:GLSI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Greenwich Lifesciences Inc
NASDAQ:GLSI
|
US |
|
L
|
Liaoning Cheng Da Co Ltd
SSE:600739
|
CN |
|
V
|
Venture Global Inc
NYSE:VG
|
US |
|
Innospec Inc
NASDAQ:IOSP
|
US |
|
DS Smith PLC
LSE:SMDS
|
UK |
|
Owlet Inc
NYSE:OWLT
|
US |
|
Mulberry Group PLC
LSE:MUL
|
UK |
|
4
|
4C Group AB
STO:4C
|
SE |
|
Chevron Corp
NYSE:CVX
|
US |
|
IHI Corp
TSE:7013
|
JP |
|
B
|
Beforepay Group Ltd
ASX:B4P
|
AU |
|
Cousins Properties Inc
NYSE:CUZ
|
US |
|
N
|
N-Able Inc
NYSE:NABL
|
US |
|
Liquidia Corp
NASDAQ:LQDA
|
US |
|
UBE Corp
TSE:4208
|
JP |
|
D'Ieteren Group NV
XBRU:DIE
|
BE |
|
B
|
Beijing Tianma Intelligent Control Technology Co Ltd
SSE:688570
|
CN |
|
Heidelberg Pharma AG
XETRA:HPHA
|
DE |
|
TPG RE Finance Trust Inc
NYSE:TRTX
|
US |
Bankruptcy Probability
Greenwich Lifesciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Greenwich Lifesciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Greenwich Lifesciences Inc
NASDAQ:GLSI
|
377.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Greenwich Lifesciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Greenwich Lifesciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
